These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 35346223)

  • 1. Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study.
    Khair S; Eastwood CA; Lu M; Jackson J
    Harm Reduct J; 2022 Mar; 19(1):32. PubMed ID: 35346223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island.
    Chambers LC; Hallowell BD; Zang X; Rind DM; Guzauskas GF; Hansen RN; Fuchs N; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 Oct; 108():103820. PubMed ID: 35973341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study.
    Zolopa C; Brothers TD; Leclerc P; Mary JF; Morissette C; Bruneau J; Hyshka E; Martin NK; Larney S
    Int J Drug Policy; 2022 Dec; 110():103894. PubMed ID: 36308892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study.
    Ali F; Russell C; Kaura A; Leslie P; Bayoumi AM; Hopkins S; Wells S
    PLoS One; 2023; 18(10):e0292862. PubMed ID: 37844109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.
    Speed KA; Gehring ND; Launier K; O'Brien D; Campbell S; Hyshka E
    Harm Reduct J; 2020 Oct; 17(1):72. PubMed ID: 33028363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of Canadian Healthcare and Harm Reduction Workers on Mobile Overdose Response Services: A Qualitative Study.
    Sedaghat N; Seo B; Rider N; Rioux W; Ghosh SM
    Subst Use Addctn J; 2024 Jul; 45(3):506-514. PubMed ID: 38525593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital.
    Nolan S; Kelian S; Kerr T; Young S; Malmgren I; Ghafari C; Harrison S; Wood E; Lysyshyn M; Holliday E
    Drug Alcohol Depend; 2022 Oct; 239():109608. PubMed ID: 36063622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Another tool in the toolkit"-Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site.
    Perlmutter D; Wettemann C; Fockele CE; Frohe T; Williams W; Holland N; Oliphant-Wells T; Meischke H; van Draanen J
    Int J Drug Policy; 2023 May; 115():104005. PubMed ID: 36972652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis.
    Rammohan I; Gaines T; Scheim A; Bayoumi A; Werb D
    Lancet Public Health; 2024 Feb; 9(2):e79-e87. PubMed ID: 38307685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service.
    Rioux W; Enns B; Jackson J; Quereshi H; Irvine M; Ghosh SM
    Subst Abuse Treat Prev Policy; 2023 Oct; 18(1):57. PubMed ID: 37794482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accessibility gaps of physical supervised consumption sites in Canada motivating the use of overdose response technology/phone based virtual overdose response services: a retrospective cohort study.
    Mocanu V; Viste D; Rioux W; Ghosh SM
    Lancet Reg Health Am; 2024 Jun; 34():100770. PubMed ID: 38798948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic.
    Galarneau LR; Speed K; Taylor M; Hyshka E
    Can J Public Health; 2023 Oct; 114(5):787-795. PubMed ID: 37462841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK.
    Poulter HL; Moore HJ; Ahmed D; Riley F; Walker T; Harris M
    Int J Drug Policy; 2024 Apr; 126():104367. PubMed ID: 38460217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multiple makings of a supervised consumption service in a hospital setting.
    Long C; Guimond T; Bayoumi AM; Firestone M; Strike C
    Int J Drug Policy; 2024 Jan; 123():104260. PubMed ID: 38035448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nurse-led approach to urgent results management at Sydney Sexual Health Centre demonstrates benefits to client outcomes and cost savings: a time efficiency and health system cost analysis.
    Scally E; Watts CG; Nugent C; Houghton R
    Sex Health; 2024 Feb; 21(1):NULL. PubMed ID: 38071757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of safer smoking facilities within a supervised consumption service shaped by socio-structural factors: A qualitative study.
    Pijl E; Oosterbroek T; Dirk B; Mason E
    Int J Drug Policy; 2023 Oct; 120():104158. PubMed ID: 37579616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overdoses, Reproductive Justice, and Harm Reduction.
    Cooper HLF; Rice W; Cummings J; Livingston MD; Peddireddy S; Rogers E; Dunlop A; Kramer M; Hernandez ND
    Am J Public Health; 2023 Sep; 113(9):933-935. PubMed ID: 37556788
    [No Abstract]   [Full Text] [Related]  

  • 18. Trip-killers: a concerning practice associated with psychedelic drug use.
    Yates G; Melon E
    Emerg Med J; 2024 Jan; 41(2):112-113. PubMed ID: 38123961
    [No Abstract]   [Full Text] [Related]  

  • 19. A Decentralized Model for Supervised Consumption Services.
    Braun HM; Rich JD
    J Urban Health; 2022 Apr; 99(2):332-333. PubMed ID: 35294707
    [No Abstract]   [Full Text] [Related]  

  • 20. Navigating the nexus between British Columbia's public consumption and decriminalization policies of illegal drugs.
    Ali F; Law J; Russell C; Crépault JF; Goulão JC; Lock K; Rehm J
    Health Res Policy Syst; 2024 May; 22(1):60. PubMed ID: 38783308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.